Cancer may be a pathway to cell survival under persistent hypoxia and elevated ROS: A model for solid‐cancer initiation and early development

A number of proposals have been made in the past century regarding what may drive sporadic cancers to initiate and develop. Yet the problem remains largely unsolved as none of the proposals have been widely accepted as cancer‐initiation drivers. We propose here a driver model for the initiation and early development of solid cancers associated with inflammation‐induced chronic hypoxia and reactive oxygen species (ROS) accumulation. The model consists of five key elements: (i)human cells tend to have a substantial gap between ATP demand and supply during chronic hypoxia, which would inevitably lead to increased uptake of glucose and accumulation of its metabolites; (ii) the accumulation of these metabolites will cast mounting pressure on the cells and ultimately result in the production and export of hyaluronic acid; (iii) the exported hyaluronic acid will be degraded into fragments of various sizes, serving as tissue‐repair signals, including signals for cell proliferation, cell survival and angiogenesis, which lead to the initial proliferation of the underlying cells; (iv) cell division provides an exit for the accumulated glucose metabolites using them towards macromolecular synthesis for the new cell, and hence alleviate the pressure from the metabolite accumulation; and (v) this process continues as long as the hypoxic condition persists. In tandem, genetic mutations may be selected to make cell divisions and hence survival more sustainable and efficient, also increasingly more uncontrollable. This model also applies to some hereditary cancers as their key mutations, such as BRCA for breast cancer, generally lead to increased ROS and ultimately to repression of mitochondrial activities and up‐regulation of glycolysis, as well as hypoxia; hence the energy gap, glucose‐metabolite accumulation, hyaluronic acid production and continuous cell division for survival.

[1]  A. Kibel,et al.  Tumour suppression by the human von Hippel-Lindau gene product , 1995, Nature Medicine.

[2]  M. Tammi,et al.  Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. , 1997, Free radical biology & medicine.

[3]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[4]  Manuel Théry,et al.  Cell shape and cell division. , 2006, Current opinion in cell biology.

[5]  C. R. Taylor,et al.  Working underground: respiratory adaptations in the blind mole rat. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Navdeep S. Chandel,et al.  NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration , 2011, Nature Cell Biology.

[7]  A. Welm,et al.  A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis. , 2010, Cancer research.

[8]  Pankaj Kapahi,et al.  Cellular senescence: a link between cancer and age-related degenerative disease? , 2011, Seminars in cancer biology.

[9]  P. Ratcliffe,et al.  Regulation of angiogenesis by hypoxia: role of the HIF system , 2003, Nature Medicine.

[10]  R. Tomasini,et al.  Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma , 2013, Proceedings of the National Academy of Sciences.

[11]  David M. Berman,et al.  Tissue repair and stem cell renewal in carcinogenesis , 2004, Nature.

[12]  E. Zacksenhaus,et al.  Cyclins, Cdks, E2f, Skp2, and more at the first international RB Tumor Suppressor Meeting. , 2010, Cancer research.

[13]  H. Aburatani,et al.  A meta-clustering analysis indicates distinct pattern alteration between two series of gene expression profiles for induced ischemic tolerance in rats. , 2005, Physiological genomics.

[14]  N. Yevdokimova Elevated level of ambient glucose stimulates the synthesis of high-molecular-weight hyaluronic acid by human mesangial cells. The involvement of transforming growth factor beta1 and its activation by thrombospondin-1. , 2006, Acta biochimica Polonica.

[15]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[16]  Takahiro Sawai,et al.  Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. Toole Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities , 2009, Clinical Cancer Research.

[18]  I. Weinstein,et al.  Multiple functions of p27Kip1 and its alterations in tumor cells: a review , 2000, Journal of cellular physiology.

[19]  S. Wahl Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure. , 1992, Journal of clinical immunology.

[20]  Franziska Hirschhaeuser,et al.  Lactate: a metabolic key player in cancer. , 2011, Cancer research.

[21]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[22]  Jaime Caro,et al.  Hypoxia, glucose metabolism and the Warburg’s effect , 2007, Journal of bioenergetics and biomembranes.

[23]  E. Nevo,et al.  High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat , 2013 .

[24]  D. Easton,et al.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.

[25]  K. Webster,et al.  Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Richard P. Hill,et al.  Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability , 2008, Nature Reviews Cancer.

[27]  E. Elinav,et al.  Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms , 2013, Nature Reviews Cancer.

[28]  C. Hamanishi,et al.  Hypoxia-induced hyaluronan synthesis by articular chondrocytes: the role of nitric oxide , 2006, Inflammation Research.

[29]  T. Ried,et al.  Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability , 2014, Genome research.

[30]  J. Pouysségur,et al.  Glycogen Synthesis is Induced in Hypoxia by the Hypoxia-Inducible Factor and Promotes Cancer Cell Survival , 2012, Front. Oncol..

[31]  Gabriela Kalna,et al.  ROS Production and NF-κB Activation Triggered by RAC1 Facilitate WNT-Driven Intestinal Stem Cell Proliferation and Colorectal Cancer Initiation , 2013, Cell stem cell.

[32]  M. Brand,et al.  The effect of metabolic depression on proton leak rate in mitochondria from hibernating frogs. , 2000, The Journal of experimental biology.

[33]  Amato J Giaccia,et al.  The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation. , 2005, Cancer cell.

[34]  C. Mogensen,et al.  The diabetic kidney , 2006 .

[35]  J. Ramirez,et al.  Hypoxia tolerance in mammals and birds: from the wilderness to the clinic. , 2007, Annual review of physiology.

[36]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[37]  W. Linehan,et al.  Fumarate Hydratase Deficiency in Renal Cancer Induces Glycolytic Addiction and Hypoxia-Inducible Transcription Factor 1α Stabilization by Glucose-Dependent Generation of Reactive Oxygen Species , 2009, Molecular and Cellular Biology.

[38]  B. Toole Hyaluronan promotes the malignant phenotype. , 2002, Glycobiology.

[39]  H. Shime,et al.  IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid. , 2011, International immunology.

[40]  C. Eng,et al.  Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53 , 2010, Human molecular genetics.

[41]  P. Fagenholz,et al.  Hypoxia and inflammation. , 2011, The New England journal of medicine.

[42]  M. Tammi,et al.  Transcriptional and post‐translational regulation of hyaluronan synthesis , 2011, The FEBS journal.

[43]  F. Antonicelli,et al.  Specific Protein-1 Is a Universal Regulator of UDP-glucose Dehydrogenase Expression , 2003, Journal of Biological Chemistry.

[44]  P. W. Hochachka,et al.  Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[46]  Ana M Soto,et al.  The somatic mutation theory of cancer: growing problems with the paradigm? , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[47]  N. Chandel,et al.  Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[48]  H. Senoo,et al.  Extracellular matrix regulates cell morphology, proliferation, and tissue formation. , 1994, Kaibogaku zasshi. Journal of anatomy.

[49]  L. del Peso,et al.  Hypoxia Promotes Glycogen Accumulation through Hypoxia Inducible Factor (HIF)-Mediated Induction of Glycogen Synthase 1 , 2010, PloS one.

[50]  H. Eltzschig,et al.  Hypoxia and inflammation are two sides of the same coin , 2013, Proceedings of the National Academy of Sciences.

[51]  A. Krivoruchko,et al.  Forever young: Mechanisms of natural anoxia tolerance and potential links to longevity , 2010, Oxidative medicine and cellular longevity.

[52]  R. Assoian,et al.  Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. , 1997, Current opinion in cell biology.

[53]  Y. Uchiyama,et al.  Effect of Hyaluronan Oligosaccharides on the Expression of Heat Shock Protein 72* , 2002, The Journal of Biological Chemistry.

[54]  H. Harada,et al.  Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas. , 2007, International journal of oncology.

[55]  G. Maloiy,et al.  Tissue metabolism and enzyme activities in the rodent Heterocephalus glaber, a poor temperature regulator. , 1977, Comparative biochemistry and physiology. B, Comparative biochemistry.

[56]  D. Parekh,et al.  Tumorigenesis and Neoplastic Progression The NADPH Oxidase Subunit p22 phox Inhibits the Function of the Tumor Suppressor Protein Tuberin , 2022 .

[57]  L. Peshkin,et al.  Genome sequencing reveals insights into physiology and longevity of the naked mole rat , 2011, Nature.

[58]  C. Boschek,et al.  Pyruvate kinase type M2 and its role in tumor growth and spreading. , 2005, Seminars in cancer biology.

[59]  H. Varmus,et al.  DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA , 1976, Nature.

[60]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[61]  K. Chin,et al.  A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Kaye,et al.  EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines , 2002, Journal of Clinical Neuroscience.

[63]  V. Kosma,et al.  Hyaluronan in human malignancies. , 2011, Experimental cell research.

[64]  P. Nowell,et al.  A minute chromosome in human chronic granulocytic leukemia , 1960 .

[65]  P. Choyke,et al.  Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. , 2003, American journal of human genetics.

[66]  B. Aggarwal,et al.  Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. , 2012, Antioxidants & redox signaling.

[67]  A. Seluanov,et al.  Long-lived cancer-resistant rodents as new model species for cancer research , 2013, Front. Gene..

[68]  J. Schaffer,et al.  Lipotoxicity: when tissues overeat , 2003, Current opinion in lipidology.

[69]  T. K. Hunt,et al.  Lactate stimulates endothelial cell migration , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[70]  J. Shay,et al.  Hypoxia-Inducible Factor 1 Mediates Upregulation of Telomerase (hTERT) , 2004, Molecular and Cellular Biology.

[71]  F. Buttgereit,et al.  A hierarchy of ATP-consuming processes in mammalian cells. , 1995, The Biochemical journal.

[72]  G. Kalna,et al.  Metabolic Profiling of Hypoxic Cells Revealed a Catabolic Signature Required for Cell Survival , 2011, PloS one.

[73]  Robert Stern,et al.  Hyaluronan fragments: an information-rich system. , 2006, European journal of cell biology.

[74]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[75]  Shamil R. Sunyaev,et al.  Impact of deleterious passenger mutations on cancer progression , 2012, Proceedings of the National Academy of Sciences.

[76]  E. Otukonyong,et al.  Effect of hypoxia on metabolic rate, core body temperature, and c-fos expression in the naked mole rat , 2012, International Journal of Developmental Neuroscience.

[77]  A. Knudson Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[78]  Andrei Seluanov,et al.  Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat , 2009, Proceedings of the National Academy of Sciences.

[79]  R. Wells The role of matrix stiffness in regulating cell behavior , 2008, Hepatology.

[80]  G. Brown,et al.  Cellular energy utilization and molecular origin of standard metabolic rate in mammals. , 1997, Physiological reviews.

[81]  Jason W. Locasale,et al.  Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses , 2011, Science.

[82]  M. Gaestel,et al.  Cytoskeletal Changes in Hypoxic Pulmonary Endothelial Cells Are Dependent on MAPK-activated Protein Kinase MK2* , 2002, The Journal of Biological Chemistry.

[83]  R. Assoian,et al.  Integrin-dependent activation of MAP kinase: a link to shape-dependent cell proliferation. , 1995, Molecular biology of the cell.

[84]  M. Balls,et al.  Cancer Resistance in Amphibians , 2007, Alternatives to laboratory animals : ATLA.

[85]  B. Bell,et al.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.

[86]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[87]  U. Schumacher,et al.  Hyaluronan Export by the ABC Transporter MRP5 and Its Modulation by Intracellular cGMP* , 2007, Journal of Biological Chemistry.

[88]  I. G. Fantus,et al.  The Hexosamine Biosynthesis Pathway , 2006 .

[89]  E. Nevo,et al.  Hypoxic stress tolerance of the blind subterranean mole rat: expression of erythropoietin and hypoxia-inducible factor 1 alpha. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[90]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[91]  J. Yokota,et al.  Constitutive activation of the Wnt signaling pathway by CTNNB1 (β‐catenin) mutations in a subset of human lung adenocarcinoma , 2001, Genes, chromosomes & cancer.

[92]  Yael H. Edrey,et al.  Endocrine function and neurobiology of the longest-living rodent, the naked mole-rat , 2011, Experimental Gerontology.

[93]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[94]  A. Avivi,et al.  Pronounced cancer resistance in a subterranean rodent, the blind mole-rat, Spalax: in vivo and in vitroevidence , 2013, BMC Biology.

[95]  W. Zong,et al.  Necrotic death as a cell fate. , 2006, Genes & development.

[96]  S. Weitzman,et al.  Chronic inflammation and cancer. , 2002, Oncology.

[97]  R. Stern Hyaluronan in cancer biology. , 2008, Seminars in cancer biology.

[98]  U. Schumacher,et al.  Cystic Fibrosis Transmembrane Conductance Regulator Can Export Hyaluronan , 2010, Pathobiology.

[99]  D. Satgé Analysis of Somatic Mutations in Cancer Tissues Challenges the Somatic Mutation Theory of Cancer , 2013 .

[100]  F. Sotgia,et al.  BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment , 2012, Cell cycle.

[101]  C. Maley,et al.  Peto's Paradox: evolution's prescription for cancer prevention. , 2011, Trends in ecology & evolution.

[102]  G. Melillo Hypoxia: jump-starting inflammation. , 2011, Blood.

[103]  M. Selbach,et al.  Global quantification of mammalian gene expression control , 2011, Nature.

[104]  A. Hogg,et al.  Detection of heterozygous mutations in the RB1 gene in retinoblastoma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing. , 1992, Oncogene.

[105]  L. Buck,et al.  Hypoxia tolerance in reptiles, amphibians, and fishes: life with variable oxygen availability. , 2007, Annual review of physiology.

[106]  S. Huang,et al.  Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks. , 2000, Experimental cell research.

[107]  C. Wennerås,et al.  Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils , 2004, Immunology.

[108]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[109]  R. Kosaki,et al.  Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity. , 1999, Cancer research.

[110]  P. Weigel,et al.  Hyaluronan synthase mediates dye translocation across liposomal membranes , 2012, BMC Biochemistry.

[111]  P. Noble,et al.  Hyaluronan in tissue injury and repair. , 2007, Annual review of cell and developmental biology.

[112]  Abhinav K. Jain,et al.  Nuclear Import and Export Signals in Control of Nrf2* , 2005, Journal of Biological Chemistry.

[113]  P. Okunieff,et al.  Hypoxia-induced alterations in hyaluronan and hyaluronidase. , 2005, Advances in experimental medicine and biology.

[114]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.